Hainan Shuangcheng Pharmaceuticals Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Shuangcheng Pharmaceuticals Co Ltd with three other
companies in this sector in CHINA :
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd.
sales of 297.07 million Chinese Renmimbi [US$43.53 million]
of which 71%
Zhejiang Ausun Pharmaceutical Co Ltd
(307.69 million Chinese Renmimbi [US$45.09 million]
of which 37%
was Antibacterial Products), and
Tus-Guhan Group Corp Ltd
(315.03 million Chinese Renmimbi [US$46.17 million]
of which 91%
was TCM and Tonics Manufacturing).
During the year ended December of 2019, sales at
Hainan Shuangcheng Pharmaceuticals Co Ltd were 346.65 million Chinese Renmimbi (US$50.80 million).
increase of 2.8%
versus 2018, when the company's sales were 337.24 million Chinese Renmimbi.
This was the third consecutive year of growth at Hainan Shuangcheng Pharmaceuticals Co Ltd.
Sales of Agent Medicines Business saw an increase
that was more than double the company's growth rate: sales were up
13.8% in 2019, from
79.99 million Chinese Renmimbi to 91.00 million Chinese Renmimbi.
Not all segments of Hainan Shuangcheng Pharmaceuticals Co Ltd experienced an increase in sales in 2019:
sales of Other Business fell 64.3% to 5.45 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).